If he fails to provide scientific facts, we will have to consider that he is spreading heresy trying to scare investors away from Gale/NeuVax.
I fully understand this comparison.
I am referring to the article released by PR Newswire at 8:05 am this morning about "mRNA Data of an additional Cohort...." I am wondering what all this report mean.
10 times the volume and no price action yesterday is indeed bothersome.
Would you care to provide some scientific facts that NeuVax's HER2 BC receptor may fail in Phase 3 trials? Phase 1 & 2 positive data do not agree with your unsubstantiated view.
would some one tell me what is the meaning of today's announcement and what impact it should have on RXII's share price movements?
The fact that it dropped 4 cents after this announcement is not too encouraging.
Thank you Commercialcreditconsultants!
Good to know that there are gale investors who respect my views!
Have a nice day!
Buy and hold Gale shares so that lots of lives can be saved and we enjoy huge returns on our investment in Gale!
Yup! You have sum Gale, NeuVax and Folate Binding Protein up nicely. They are going to revolutionize cancer treatment. They are very safe with very low side effects. They train our own immune system to target and kill cancer cells.
One comment I do not tend to agree is that I would rather see Gale grow on its own and become a major large cap biopharma company. I have no problem that Gale partnering with a large pharma in Europe to market NeuVax in the EU and some other Asian pharma to market NeuVax in Asian countries like China, Japan and India.
Who do you think you are?
You do not present any facts to support your statement. How dare you ask people to trust you?
Just a hunch, nothing else!
Without factual evidence, this is just a "pipe dream".
Give some facts to back up your claim of $4.23!!!
Even if it drops back to $4.00, do I really care?
I am patiently waiting to see $8 by Q1 of 2014.
Do I really care about what people have to say about $4.23 or for that matter $5.23?
I can see that we still have lots of speculators with this stock. I can also see lots of speculators using charts to predict the immediate price movements of Gale.
True long Gale investors do not give a dam about the up or down movements within 2 or 3 weeks. Talk about the fundamental values in Gale and why its share price will reach $40 in 2 to 3 years.
Bragging about making 100% returns to ones investment in Gale is, in my view, totally childish. Start sharing your successful investment in Gale when you make 3,000% net profits in 2 to 3 years time.
I will be here 2 years from now. I will share with you my success story by that time.
Strong buy and hold Gale shares!!!
I do not like people who use lies on either claiming price movements up or down. These LIARs do not and will not give some verifiable facts to back up their positive or negative claims.
You may think I am totally stupid and waste my time. Let them lie, is that it?
Thanks for sharing!
With revenues to be generated by Abstral, Gale will not need for additional funding of Gale's operations. This will prevent anybody from claiming that Gale may need further funding in the next few years.
There is a mild profit taking today. Yet, Gale has as many buyers (so far 10 million) as sellers and its share price is only slightly lower than yesterday's closing price.
An idiot was saying that FDA approval of NeuVax is 3 years away. Sure, no body is going to argue with that. Meanwhile, during these 3 years, there will be positive interim data. The will be the possibility of partnership for a European company to market NeuVax in the EU, there will be positive interim data on the Phase 2a (NeuVax + Herceptin combo) and positive results for FBP Phase 2. All these should have some power to lift Gale's share price higher than its current level.
Really nice that you share this with us.
For sure that Gale will not need raise more capital to finance the clinical trials of NeuVax and Folale Binding Protein and its future operations.
Any more good news on the Phase 3 of NeuVax or partnership with an EU company to market NeuVax there will lift Gale's share price way higher than the current level of around $4.50.
More long Gale investors may want to assure themselves that Gale has substantial support from 12 reputable investment analysts.
It appears that buyers do not believe these outrageous negative proclamations!
True, it is natural that after a long steady price climb, there may be a pause. I do not think that any investor would deny this fact.
Yet, keep loading this board with unsubstantiated and empty proclamations that some major pullback is on the horizon is totally irresponsible!
If those bashers want to use these irresponsible claims to push Gale's share price down, I think they are dreaming.
Why? Institution buyers are moving in and they professionals and they have conduct thorough DD. On the part of the retail investors, I have seen more than 70 "long" responses and they are very knowledgeable about the long term strength and potential of Gale.
Now, I want bashers to answer my question: Who do you think you can successfully fool and scare?
Strong buy and hold Gale shares!
All indices of the overall market are down.
Gale's volume has reached 2.5 million share only half an hour after open and its price has moved up to $4.66 which is 16 cents higher than yesterday's closing price.
What will it be when Dec 10th arrives?
Soon some of these 12 analysts will up-grade their target prices on Gale. What will be their next price target for Gale?
A weighted average of $10?